跳至主要内容
临床试验/RPCEC00000377
RPCEC00000377尚未招募4 期

Effects of policosanol on blood pressure values and lipid profile in patients with pre-hypertension or with grade I hypertension. - PoliHTA-01

ational Center for Scientific Research0 个研究点开始时间: 2021年6月30日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Treatment

入排标准

年龄范围
30 years 至 59 years(—)
性别
All

入选标准

  • 1) Patients with pre-hypertension (SBP: 120-139, DBP: 80-89 mmHg),
  • 2) Patients with grade I hypertension (SBP: 140-159, DBP: 90-99 mmHg),
  • 3) With one or two cardiovascular risk factors,
  • 4) Without previous antihypertensive treatment,
  • 5) Of both sexes,
  • 6) Aged between 30 and 59 years,
  • 7) Without a history of diagnosed vascular diseases,
  • 8) Who agreed to participate in the study, signing your informed consent.

排除标准

  • Patients with:
  • 1) Grade II hypertension (SBP: 160-179, DBP: 100-109 mmHg)
  • 2) Grade III hypertension (SBP: 180 and more, DBP: 110 mmHg and more).
  • 3) Isolated systolic hypertension (SBP: 140 and more, DBP less than 90 mmHg).
  • 4) Vascular diseases (coronary, cerebrovascular, peripheral) diagnosed.
  • 5) Diagnosed neoplasms.
  • 6) Diseases or use of medications that could affect blood pressure: endocrinopathies, use of glucorticoids, malabsorption, psychotropic drugs, etc.
  • 7) Any other special condition that at the discretion of the doctor puts your health and life at risk during the study.

研究者

发起方
ational Center for Scientific Research

相似试验